Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalMarket Capitalization

RedHill Biopharma (RDHL) Return on Capital Employed: 2014-2023

Historic Return on Capital Employed for RedHill Biopharma (RDHL) over the last 1 years, with Jun 2023 value amounting to -2.34%.

  • RedHill Biopharma's Return on Capital Employed rose 13486.00% to -2.34% in Q2 2023 from the same period last year, while for Jun 2023 it was -2.34%, marking a year-over-year increase of 13486.00%. This contributed to the annual value of 8.71% for FY2024, which is 853.00% up from last year.
  • RedHill Biopharma's Return on Capital Employed amounted to -2.34% in Q2 2023, which was down 197.90% from 2.40% recorded in Q4 2022.
  • RedHill Biopharma's Return on Capital Employed's 5-year high stood at 2.40% during Q4 2022, with a 5-year trough of -137.20% in Q2 2022.
  • Its 3-year average for Return on Capital Employed is -27.44%, with a median of -0.79% in 2021.
  • As far as peak fluctuations go, RedHill Biopharma's Return on Capital Employed slumped by 13,797bps in 2022, and later skyrocketed by 13,486bps in 2023.
  • RedHill Biopharma's Return on Capital Employed (Quarterly) stood at 0.93% in 2019, then decreased by 6bps to 0.87% in 2020, then tumbled by 166bps to -0.79% in 2021, then surged by 319bps to 2.40% in 2022, then skyrocketed by 13,486bps to -2.34% in 2023.
  • Its last three reported values are -2.34% in Q2 2023, 2.40% for Q4 2022, and -137.20% during Q2 2022.